TAZICEF

Product NDC: 0409-5092
11-digit product format: 004095092
Labeler code: 0409
Product ID: 0409-5092_3f749ee0-db14-4ed0-9056-d545a38bbe3b
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: CEFTAZIDIME
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Labeler: Hospira, Inc.
Application: ANDA064032
Marketing category: ANDA
Marketing start: 2006-05-08
Marketing end: 0000-00-00
Substance: CEFTAZIDIME
Active strength: 1 g/1
Pharmacologic classes: Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	0409-5092		D	Discontinued by firm		2026-10-15
excluded package	package	0409-5092	0409-5092-16	D	Discontinued by firm		2026-10-15

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A064032-001	TAZICEF	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP		1993-10-31
A064032-002	TAZICEF	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP		1993-10-31

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A064032-001	AP
A064032-002	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 88 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`4b0b4de00fa7…`

Observed Orange Book normalized TE history#

Normalized TE history page 2 of 3 · 88 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A064032-001	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A064032-002	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A064032-001	AP	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A064032-002	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A064032-001	AP	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A064032-002	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A064032-001	AP	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A064032-002	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A064032-001	AP	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A064032-002	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A064032-001	AP	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A064032-002	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A064032-001	AP	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A064032-002	AP	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A064032-001	AP	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A064032-002	AP	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A064032-001	AP	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A064032-002	AP	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A064032-001	AP	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A064032-002	AP	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A064032-001	AP	1	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A064032-002	AP	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A064032-001	AP	1	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	A064032-002	AP	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A064032-001	AP	1	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	A064032-002	AP	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A064032-001	AP	1	`a72a2bbeb626…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A064032-002	AP	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A064032-001	AP	1	`9b2671bbb829…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A064032-002	AP	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A064032-001	AP	1	`a67488948f0b…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A064032-002	AP	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A064032-001	AP	1	`3f0d92c62455…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A064032-002	AP	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A064032-001	AP	1	`053a50430f4f…`
2023-05-13 08:27 UTC	2023-05	A064032-002	AP	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A064032-001	AP	1	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	A064032-002	AP	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A064032-001	AP	1	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A064032-002	AP	1	`3a93d1ddd44b…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fb7d24f2-fcd1-4dc6-b9d0-b1f65bfffab5	Product name	1	20150409

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0409-5092-11	TAZICEF	1 in 1 VIAL, PATENT DELIVERY SYSTEM	INJECTION, POWDER, FOR SOLUTION	1		29
0409-5092-16	TAZICEF	25 in 1 TRAY	INJECTION, POWDER, FOR SOLUTION	25		29

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0409-5092-11	EA - Each	0409-5092	31a8b96a-ce51-4979-91cd-37556810afa6	1	2019-08-06
0409-5092-16	EA - Each	0409-5092	3fa85688-74be-4814-9abe-b8a105760bc3	1	2012-07-24
0409-5092-52	EA - Each	0409-5092	0b0a3b10-f7ab-4f39-b690-32033459d70c	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEFTAZIDIME	ACTIVE INGREDIENT	9M416Z9QNR	TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]	14
CEFTAZIDIME ANHYDROUS	ACTIVE MOIETY	DZR1ENT301	TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]	14
SODIUM CARBONATE	INACTIVE INGREDIENT	45P3261C7T	TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]	14

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0409-5092	TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]	29	Legacy NDC, 2 package rows	20211103_9b73979c-c95a-4433-0a9d-f9cea3cb557f.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
9M416Z9QNR	CEFTAZIDIME	78439-06-2	CEFTAZIDIME

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1659283	cefTAZidime 1 GM Injection	PSN	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659287	cefTAZidime 2 GM Injection	PSN	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659292	Tazicef 1 GM Injection	PSN	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659294	Tazicef 2 GM Injection	PSN	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659292	ceftazidime 1000 MG Injection [Tazicef]	SBD	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659294	ceftazidime 2000 MG Injection [Tazicef]	SBD	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659283	ceftazidime 1000 MG Injection	SCD	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659287	ceftazidime 2000 MG Injection	SCD	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659283	ceftazidime (as ceftazidime pentahydrate) 1000 MG Injection	SY	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659287	ceftazidime (as ceftazidime pentahydrate) 2000 MG Injection	SY	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659283	ceftazidime 1 GM Injection	SY	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659287	ceftazidime 2 GM Injection	SY	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659292	Tazicef 1000 MG Injection	SY	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659294	Tazicef 2000 MG Injection	SY	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0409-5092-11	00409509211	1 in 1 VIAL, PATENT DELIVERY SYSTEM					Historical
0409-5092-16	00409509216	25 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-5092-16) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (0409-5092-11)	2006-05-08	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
TAZICEF ® brand of ceftazidime for injection, USP	Hospira, Inc. \| Sandoz GmbH	2026-06-04	HUMAN PRESCRIPTION DRUG LABEL	30